Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Amyris Signs Deal For Squalane Production

by MMB MMB
January 10, 2011 | A version of this story appeared in Volume 89, Issue 2

Renewable chemicals firm Amyris has signed agreements with two partners to convert bioderived farnesene into finished specialty chemicals. The first product will be squalane, a triterpene primarily used in cosmetics. Glycotech will provide the chemical processing at a facility in Leland, N.C., owned by Salisbury Partners. The plant can also provide finishing services for lubricants, polymers, and fuels that Amyris plans to make. The firm previously reported that its farnesene will be manufactured by Biomin in Brazil and Tate & Lyle in Illinois.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.